4.5 Article

Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab

Anne Hu et al.

Summary: This study found that combination therapy with immunomodulators did not increase rates of clinical remission or response, endoscopic remission, or persistence of therapy in patients with CD or UC receiving ustekinumab or vedolizumab therapy.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis

Seth R. Shaffer et al.

Summary: This study assessed the cost-effectiveness of discontinuing 5-ASA therapy in patients with ulcerative colitis on biological therapies or tofacitinib, compared with continuing 5-ASA therapy. The results showed that discontinuing 5-ASA therapy is a cost-effective and more effective strategy in these patients.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016

Katsuyoshi Matsuoka et al.

Summary: The study found that long-term corticosteroid use became more appropriate as the use of thiopurines and biologics increased; however, there were still many cases of inappropriate use, with low initial doses of corticosteroids being most strongly associated with long-term use.

JOURNAL OF CROHNS & COLITIS (2021)

Article Gastroenterology & Hepatology

Trends in Corticosteroid Use During the Era of Biologic Therapy: A Population-Based Analysis

Laura E. Targownik et al.

Summary: Over the past two decades, the use of corticosteroids has decreased in both Crohn's disease and ulcerative colitis patients, with a more pronounced decline seen after 2007 in Crohn's disease. Potential reasons include the introduction and increasing use of biologic therapy for Crohn's disease and greater awareness of corticosteroid-related adverse events in IBD.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Clinical Neurology

Accelerating diagnosis of Parkinson's disease through risk prediction

William Yuan et al.

Summary: This study explores the characterization of prediagnostic Parkinson's Disease and constructs a prediction model using machine learning, which not only identifies novel features but also allows for guiding clinical decisions and the possibility of earlier diagnosis for disease modifying therapies in clinical trials.

BMC NEUROLOGY (2021)

Article Gastroenterology & Hepatology

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Joseph D. Feuerstein et al.

GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Biologic Therapy for Ulcerative Colitis

Abhik Bhattacharya et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)

Article Medicine, General & Internal

Ulcerative colitis

Taku Kobayashi et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Article Endocrinology & Metabolism

Evaluation of the association of bariatric surgery with subsequent depression

William Yuan et al.

INTERNATIONAL JOURNAL OF OBESITY (2019)

Article Gastroenterology & Hepatology

ACG Clinical Guideline: Ulcerative Colitis in Adults

David T. Rubin et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Medicine, General & Internal

Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study

Gabriel A. Brat et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Medicine, General & Internal

Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study

Gabriel A. Brat et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Pharmacology & Pharmacy

Treatment Patterns and Sequencing in Patients With Inflammatory Bowel Disease

Joanne E. Brady et al.

CLINICAL THERAPEUTICS (2018)

Article Pediatrics

Association of Sex With Recurrence of Autism Spectrum Disorder Among Siblings

Nathan Palmer et al.

JAMA PEDIATRICS (2017)

Article Gastroenterology & Hepatology

A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease

C. P. Selinger et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Gastroenterology & Hepatology

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

William J. Sandborn et al.

GASTROENTEROLOGY (2012)

Review Gastroenterology & Hepatology

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Natalie A. Molodecky et al.

GASTROENTEROLOGY (2012)

Review Gastroenterology & Hepatology

Systematic review: the costs of ulcerative colitis in Western countries

R. D. Cohen et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)

Article Gastroenterology & Hepatology

Azathioprine Maintains Long-term Steroid-free Remission Through 3 Years in Patients with Steroid-dependent Ulcerative Colitis

Liliana Andrade Chebli et al.

INFLAMMATORY BOWEL DISEASES (2010)

Article Medicine, General & Internal

Infliximab for induction and maintenance therapy for ulcerative colitis

P Rutgeerts et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

SB Hanauer et al.

LANCET (2002)